Analysts at Lifesci Capital upped their FY2024 earnings per share estimates for Spyre Therapeutics in a report released on Tuesday, January 14th. Lifesci Capital analyst S. Slutsky now anticipates ...
A total of 50.1% expressed approval of how the Russian government is managing the country (a decrease of 0.2%), while 52% approved of Prime Minister Mikhail Mishustin’s performance (a decrease of 0.2% ...
Leonid Slutsky drew attention to NATO Secretary General Mark Rutte’s words that Europeans will have to learn Russian or move to New Zealand if EU countries don’t invest in military production ...